Status:
UNKNOWN
COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
University Hopsital Schleswig Holstein Campus Lübeck
University Hospital Schleswig-Holstein
Conditions:
Cancer
COVID
Eligibility:
All Genders
18+ years
Brief Summary
The COVIDHELP study will prospectively evaluate the yet unknown clinical course of the COVID-19 infection in cancer patients and document the impact of potential infrastructural limitations on cancer ...
Detailed Description
Based on patients, who are treated in the University Cancer Center Hamburg (UCCH) and its contracted partner network, which comprises all cancer treating departments at the University Medical Center o...
Eligibility Criteria
Inclusion
- Key inclusion criteria:
- Known diagnosis of cancer
- Known diagnosis of CoVID-19 infection
- Age ≥ 18 years
- Signed informed consent
- Key exclusion criteria:
- • refusal of participation
Exclusion
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 14 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04408339
Start Date
April 15 2020
End Date
April 14 2022
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hamburg Eppendorf
Hamburg, Germany